269 related articles for article (PubMed ID: 14757847)
1. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation.
Weisenberger DJ; Velicescu M; Cheng JC; Gonzales FA; Liang G; Jones PA
Mol Cancer Res; 2004 Jan; 2(1):62-72. PubMed ID: 14757847
[TBL] [Abstract][Full Text] [Related]
2. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine.
Oka M; Meacham AM; Hamazaki T; Rodić N; Chang LJ; Terada N
Oncogene; 2005 Apr; 24(19):3091-9. PubMed ID: 15735669
[TBL] [Abstract][Full Text] [Related]
3. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.
Hattori N; Abe T; Hattori N; Suzuki M; Matsuyama T; Yoshida S; Li E; Shiota K
Genome Res; 2004 Sep; 14(9):1733-40. PubMed ID: 15310660
[TBL] [Abstract][Full Text] [Related]
4. The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation.
Zeng Y; Ren R; Kaur G; Hardikar S; Ying Z; Babcock L; Gupta E; Zhang X; Chen T; Cheng X
Genes Dev; 2020 Nov; 34(21-22):1546-1558. PubMed ID: 33004415
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifications affect Dnmt3L expression.
Aapola U; Mäenpää K; Kaipia A; Peterson P
Biochem J; 2004 Jun; 380(Pt 3):705-13. PubMed ID: 15015937
[TBL] [Abstract][Full Text] [Related]
6. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
8. Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family.
Chen ZX; Mann JR; Hsieh CL; Riggs AD; Chédin F
J Cell Biochem; 2005 Aug; 95(5):902-17. PubMed ID: 15861382
[TBL] [Abstract][Full Text] [Related]
9. Methylation silencing of the Apaf-1 gene in acute leukemia.
Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10060-5. PubMed ID: 12110732
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells.
Rodić N; Oka M; Hamazaki T; Murawski MR; Jorgensen M; Maatouk DM; Resnick JL; Li E; Terada N
Stem Cells; 2005 Oct; 23(9):1314-23. PubMed ID: 16051982
[TBL] [Abstract][Full Text] [Related]
12. Analysis of DNA methylation change induced by Dnmt3b in mouse hepatocytes.
Takahashi M; Kamei Y; Ehara T; Yuan X; Suganami T; Takai-Igarashi T; Hatada I; Ogawa Y
Biochem Biophys Res Commun; 2013 May; 434(4):873-8. PubMed ID: 23611774
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
14. Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.
Kwon O; Jeong SJ; Kim SO; He L; Lee HG; Jang KL; Osada H; Jung M; Kim BY; Ahn JS
Carcinogenesis; 2010 Jul; 31(7):1194-201. PubMed ID: 20375073
[TBL] [Abstract][Full Text] [Related]
15. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras.
Soejima K; Fang W; Rollins BJ
Oncogene; 2003 Jul; 22(30):4723-33. PubMed ID: 12879017
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells.
Xiong Y; Dowdy SC; Podratz KC; Jin F; Attewell JR; Eberhardt NL; Jiang SW
Cancer Res; 2005 Apr; 65(7):2684-9. PubMed ID: 15805266
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
Bender CM; Pao MM; Jones PA
Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
20. CpG sites preferentially methylated by Dnmt3a in vivo.
Oka M; Rodić N; Graddy J; Chang LJ; Terada N
J Biol Chem; 2006 Apr; 281(15):9901-8. PubMed ID: 16439359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
